These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 35063123)

  • 21. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
    Shaw RH; Stuart A; Greenland M; Liu X; Nguyen Van-Tam JS; Snape MD;
    Lancet; 2021 May; 397(10289):2043-2046. PubMed ID: 33991480
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.
    Sieghart D; Hana CA; Dürrschmid C; Heinz LX; Haslacher H; Zlesak M; Piccini G; Manenti A; Montomoli E; Jorda A; Fedrizzi C; Hasenoehrl T; Zdravkovic A; Anderle K; Wiedermann U; Drapalik S; Steinbrecher H; Bergmann F; Firbas C; Jordakieva G; Wagner B; Leonardi M; Pierleoni G; Ballini M; Benincasa L; Marchi S; Trombetta C; Perkmann T; Crevenna R; Zeitlinger M; Bonelli M; Aletaha D; Radner H
    J Clin Virol; 2024 Aug; 173():105661. PubMed ID: 38503118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients.
    Maillard A; Redjoul R; Klemencie M; Labussière Wallet H; Le Bourgeois A; D'Aveni M; Huynh A; Berceanu A; Marchand T; Chantepie S; Botella Garcia C; Loschi M; Joris M; Castilla-Llorente C; Thiebaut-Bertrand A; François S; Leclerc M; Chevallier P; Nguyen S
    Blood; 2022 Jan; 139(1):134-137. PubMed ID: 34818411
    [No Abstract]   [Full Text] [Related]  

  • 24. Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.
    Chan WY; Howells L; Wilson W; Sanchez E; Ainley L; Chavda SJ; Dowling E; Correia N; Lecat CSY; McMillan A; Wisniowski B; Mahmood S; Papanikolaou X; Lee L; Sive J; Kyriakou C; Wechalekar A; Popat R; Rabin N; Nastouli E; Yong KL; Xu K
    Br J Haematol; 2022 Feb; 196(3):e21-e26. PubMed ID: 34632575
    [No Abstract]   [Full Text] [Related]  

  • 25. Correlation of vaccine-elicited antibody levels and neutralizing activities against SARS-CoV-2 and its variants.
    Liu J; Bodnar BH; Padhiar NH; Khan AI; Meng F; Saribas S; Wang P; Wang X; McCluskey E; Shah S; Zhao H; Luo JJ; Hu WH; Ho WZ
    Clin Transl Med; 2021 Dec; 11(12):e644. PubMed ID: 34923762
    [No Abstract]   [Full Text] [Related]  

  • 26. COVID-19 vaccine breakthrough infections.
    Gupta RK; Topol EJ
    Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
    Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
    Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
    [No Abstract]   [Full Text] [Related]  

  • 28. Waning of SARS-CoV-2 booster viral-load reduction effectiveness.
    Levine-Tiefenbrun M; Yelin I; Alapi H; Herzel E; Kuint J; Chodick G; Gazit S; Patalon T; Kishony R
    Nat Commun; 2022 Mar; 13(1):1237. PubMed ID: 35246560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis.
    Sibbel S; McKeon K; Luo J; Wendt K; Walker AG; Kelley T; Lazar R; Zywno ML; Connaire JJ; Tentori F; Young A; Brunelli SM
    J Am Soc Nephrol; 2022 Jan; 33(1):49-57. PubMed ID: 34789546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain.
    Jiménez-Sepúlveda N; Gras-Valentí P; Chico-Sánchez P; Castro-García JM; Ronda-Pérez E; Vanaclocha H; Peiró S; Burgos JS; Ana Berenguer ; Navarro D; Sánchez-Payá J;
    Vaccine; 2024 Jul; 42(19):4011-4021. PubMed ID: 38760269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period.
    Kim JY; Lim SY; Park S; Kwon JS; Bae S; Park JY; Cha HH; Seo MH; Lee HJ; Lee N; Kim K; Shum D; Jee Y; Kim SH
    J Infect Dis; 2022 Mar; 225(5):777-784. PubMed ID: 34850034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia.
    Dashdorj NJ; Wirz OF; Röltgen K; Haraguchi E; Buzzanco AS; Sibai M; Wang H; Miller JA; Solis D; Sahoo MK; Arunachalam PS; Lee AS; Shah MM; Liu J; Byambabaatar S; Bat-Ulzii P; Enkhbat A; Batbold E; Zulkhuu D; Ochirsum B; Khurelsukh T; Dalantai G; Burged N; Baatarsuren U; Ariungerel N; Oidovsambuu O; Bungert AS; Genden Z; Yagaanbuyant D; Mordorj A; Pulendran B; Chinthrajah S; Nadeau KC; Jardetzky T; Wilbur JL; Wohlstadter JN; Sigal GB; Pinsky BA; Boyd SD; Dashdorj ND
    Cell Host Microbe; 2021 Dec; 29(12):1738-1743.e4. PubMed ID: 34861167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
    Grunau B; Goldfarb DM; Asamoah-Boaheng M; Golding L; Kirkham TL; Demers PA; Lavoie PM
    JAMA; 2022 Jan; 327(3):279-281. PubMed ID: 34860253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina.
    Garza-Silva A; Rivera-Salinas D; Rivera-Cavazos A; Fernández-Chau IF; Cepeda-Medina AB; Morales-Rodríguez DP; Barco-Flores IA; Sanz-Sánchez MÁ; Acciardi C; Paez-Bo G; Teixeira MM; Azzolini E; Pozzi C; Rescigno M; Romero-Ibarguengoitia ME
    Front Immunol; 2024; 15():1403784. PubMed ID: 38807602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection by Type and Frequency of Vaccine: A Community-Based Case-Control Study.
    Gim H; Seo H; Chun BC
    J Korean Med Sci; 2024 Jun; 39(21):e174. PubMed ID: 38832478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals.
    Uprichard SL; O'Brien A; Evdokimova M; Rowe CL; Joyce C; Hackbart M; Cruz-Pulido YE; Cohen CA; Rock ML; Dye JM; Kuehnert P; Ricks KM; Casper M; Linhart L; Anderson K; Kirk L; Maggiore JA; Herbert AS; Clark NM; Reid GE; Baker SC
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions.
    Lee SW; Moon JY; Lee SK; Lee H; Moon S; Chung SJ; Yeo Y; Park TS; Park DW; Kim TH; Sohn JW; Yoon HJ; Kim SH
    Front Immunol; 2021; 12():779212. PubMed ID: 34899739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.
    Carreño JM; Alshammary H; Tcheou J; Singh G; Raskin AJ; Kawabata H; Sominsky LA; Clark JJ; Adelsberg DC; Bielak DA; Gonzalez-Reiche AS; Dambrauskas N; Vigdorovich V; ; Srivastava K; Sather DN; Sordillo EM; Bajic G; van Bakel H; Simon V; Krammer F
    Nature; 2022 Feb; 602(7898):682-688. PubMed ID: 35016197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 timeline of events.
    Webster P
    Nat Med; 2021 Dec; 27(12):2054-2055. PubMed ID: 34907389
    [No Abstract]   [Full Text] [Related]  

  • 40. Homologous and Heterologous Covid-19 Booster Vaccinations.
    Atmar RL; Lyke KE; Deming ME; Jackson LA; Branche AR; El Sahly HM; Rostad CA; Martin JM; Johnston C; Rupp RE; Mulligan MJ; Brady RC; Frenck RW; Bäcker M; Kottkamp AC; Babu TM; Rajakumar K; Edupuganti S; Dobrzynski D; Coler RN; Posavad CM; Archer JI; Crandon S; Nayak SU; Szydlo D; Zemanek JA; Dominguez Islas CP; Brown ER; Suthar MS; McElrath MJ; McDermott AB; O'Connell SE; Montefiori DC; Eaton A; Neuzil KM; Stephens DS; Roberts PC; Beigel JH;
    N Engl J Med; 2022 Mar; 386(11):1046-1057. PubMed ID: 35081293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.